Andreas Marzinzik at Novartis to speak at Drug Design Medicinal...
www.prlog.org
Aug. 16, PRLog -- Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes ...
Combinatorial Chemistry: A Practical Approach - Google Books
books.google.de
Kurz vor der Jahrtausendwende hat die Synthesechemie nochmals einen signifikanten Innovationsschub erfahren: Die effiziente Herstellung einer Vielfalt von...
The Fifth International Electronic Conference on Synthetic Organic ...
www.mdpi.org
... University of Zaragoza (Spain), .es B. Solid Phase Chemistry and Combinatorial Synthesis Convener: Dr. Andreas Marzinzik, Novartis ...
5th Electronic Conference on Synthetic Organic Chemistry
www.ccl.net
... Combinatorial Synthesis Convener: Dr. Andreas Marzinzik, Novartis Pharma AG (Switzerland), andreas.marzinzik()at()pharma.novartis.com ...
sciforum
ecsoc-5.sciforum.net
The 5th International Electronic Conference on Synthetic Organic Chemistry
Alle Infos zum Namen "Andreas Marzinzik"
Andreas Marzinzik | Novartis | Switzerland - OMICS Internationalbiography.omicsonline.org › andre...
biography.omicsonline.org
Andreas Marzinzik currently working as an Director at Novartis.He completed his Dr.rer.nat.(PhD) Organic Chemistry at University of Essen,in
Andreas Marzinzik at Novartis to Speak at Drug Design Medicinal...
www.sbwire.com
Press Release issued Aug 17, 2011: Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for...
1888 PressRelease.com - Latest Press Releases - Free Press Release...
rss2.com
Andreas Marzinzik, Director of Exploratory Medicinal Chemistry and Global Discovery Chemistry at Novartis Institutes for BioMedical Research, will give a ...
ECSOC Organizing Committeewww.mdpi.net/ecsoc-5/organize.htm
www.mdpi.net
Dr. Andreas Marzinzik, Chairman of Solid Phase Chemistry and Combinatorial Synthesis Symposium (SPCCSS2001) Program Head - ICLF Novartis Pharma ...
Pardon Our Interruption
www.drugdiscoverychemistry.com
Andreas Marzinzik, Ph.D., Director, Lead Generation Chemistry, Novartis Institutes for BioMedical Research. ABL001 is a potent, selective BCR-ABL inhibitor ...
Going Beyond the Bone :: ChemViews Magazine ...www.chemistryviews.org › ezine
www.chemistryviews.org
... at the Novartis Institutes for Biomedical Research led by Wolfgang Jahnke and Andreas Marzinzik, discovered new FPPS inhibitors.
List of Contributors - Combinatorial Chemistry
www.pharmacologicalsciences.us
... Postfach D Wuppertal Germany. Thomas Krämer Bayer AG PH-R-CR MCS Postfach D Wuppertal Germany. Andreas Marzinzik.
Program - Swiss Industrial Chemistry Symposium 2016sics16.chemistrycongresses.ch › pr...
sics16.chemistrycongresses.ch
08.30, Welcome coffee, registration , Opening, welcome. Dr. Remo Gamboni, F. Hoffmann-La Roche , Dr. Andreas Marzinzik, Novartis Pharma AG
The 5th Electronic Conference on Synthetic Organic Chemistrywww.mdpi.net/ecsoc/ecsoc-5/start.htm
www.mdpi.net
Editors : Oliver Kappe, Pedro Merino, Andreas Marzinzik, Helma Wennemers,. Thomas Wirth, Jean-Jacques Vanden Eynde and Shu-Kun Lin. Proceedings of ...
Triazine cycloadditions - high pressure vs
www.mdpi.org
Margetic, D.; Johnston, M. R.; Warrener, R. N.; Butler, D. N., Article 37, The Fifth International Electronic Conference on Synthetic Organic Chemistry (ECSOC-5), http://www.mdpi.org/ecsoc-5.htm, September 1-30, 2001, Editors: Oliver Kappe, Pedro Merino, Andreas Marzinzik, Helma Wennemers, Thomas Wirth, ...
ECSOC Announcement
www.mdpi.org
Convener: Dr. Andreas Marzinzik, Novartis Pharma AG (Switzerland), .com C. Bioorganic Chemistry and Natural Products
Verwandte Suchanfragen zu Andreas Marzinzik
| Kirk Wright Martin Geiser Clemens Scheufler | Johannes Ottl Kristina Burow Claus Ehrhardt | Nils Ostermann |
Personen Vorname "Andreas" (97752) Name "Marzinzik" (71) |
sortiert nach Relevanz / Datum